Tags

Type your tag names separated by a space and hit enter

Acceptance of a COVID-19 Vaccine Before it is Available in China During the Pandemic.
Int J Public Health. 2021; 66:1604092.IJ

Abstract

Objectives: China was believed to be the country with the world's highest acceptance rate of the COVID-19 vaccine following several investigations. This study aims to explore the Chinese acceptance of a COVID-19 vaccine before it is made available, including its determinants. Methods: A cross-national online survey was conducted covering all 31 provinces of mainland China. The survey consists of the demographic variables, acceptance of a self-paid COVID-19 vaccine as the dependent variable, and the 3Cs factors (i.e., confidence, convenience, and complacency) as the independent variables. Results: Among the 1,532 participants, 57.9% accepted to get a self-paid COVID-19 vaccine. COVID-19 vaccine acceptors were more likely to be concerned about the effectiveness of the vaccines, believe that they were at risk of COVID-19 infection, have a high perceived susceptibility of COVID-19, and trust in the health care system. Conclusion: Findings indicate that the critical task in the early stage of the COVID-19 vaccine development in China is to increase the tolerance to some intuitive concerns about the vaccines, put more emphasis on the communication of the saliency of the disease threats, and effectively translate people's trust in the government into vaccine acceptance.

Links

PMC Free PDF

Authors+Show Affiliations

Xu J
School of Media and Communication, Shanghai Jiao Tong University, Shanghai, China. China Institute for Urban Governance, Shanghai Jiao Tong University, Shanghai, China. Institute of Cultural Innovation and Youth Development, Shanghai Jiao Tong University, Shanghai, China.
Liu C
School of Media and Communication, Shanghai Jiao Tong University, Shanghai, China. Institute of Cultural Innovation and Youth Development, Shanghai Jiao Tong University, Shanghai, China.

MeSH

COVID-19COVID-19 VaccinesChinaHumansPandemicsPatient Acceptance of Health Care

Pub Type(s)

Journal Article

Language

eng

PubMed ID

34744597

Citation

Xu, Jian, and Cong Liu. "Acceptance of a COVID-19 Vaccine Before It Is Available in China During the Pandemic." International Journal of Public Health, vol. 66, 2021, p. 1604092.
Xu J, Liu C. Acceptance of a COVID-19 Vaccine Before it is Available in China During the Pandemic. Int J Public Health. 2021;66:1604092.
Xu, J., & Liu, C. (2021). Acceptance of a COVID-19 Vaccine Before it is Available in China During the Pandemic. International Journal of Public Health, 66, 1604092. https://doi.org/10.3389/ijph.2021.1604092
Xu J, Liu C. Acceptance of a COVID-19 Vaccine Before It Is Available in China During the Pandemic. Int J Public Health. 2021;66:1604092. PubMed PMID: 34744597.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Acceptance of a COVID-19 Vaccine Before it is Available in China During the Pandemic. AU - Xu,Jian, AU - Liu,Cong, Y1 - 2021/10/25/ PY - 2021/3/20/received PY - 2021/9/27/accepted PY - 2021/11/8/entrez PY - 2021/11/9/pubmed PY - 2021/11/10/medline KW - COVID-19 KW - China KW - acceptance KW - pandemic KW - vaccine SP - 1604092 EP - 1604092 JF - International journal of public health JO - Int J Public Health VL - 66 N2 - Objectives: China was believed to be the country with the world's highest acceptance rate of the COVID-19 vaccine following several investigations. This study aims to explore the Chinese acceptance of a COVID-19 vaccine before it is made available, including its determinants. Methods: A cross-national online survey was conducted covering all 31 provinces of mainland China. The survey consists of the demographic variables, acceptance of a self-paid COVID-19 vaccine as the dependent variable, and the 3Cs factors (i.e., confidence, convenience, and complacency) as the independent variables. Results: Among the 1,532 participants, 57.9% accepted to get a self-paid COVID-19 vaccine. COVID-19 vaccine acceptors were more likely to be concerned about the effectiveness of the vaccines, believe that they were at risk of COVID-19 infection, have a high perceived susceptibility of COVID-19, and trust in the health care system. Conclusion: Findings indicate that the critical task in the early stage of the COVID-19 vaccine development in China is to increase the tolerance to some intuitive concerns about the vaccines, put more emphasis on the communication of the saliency of the disease threats, and effectively translate people's trust in the government into vaccine acceptance. SN - 1661-8564 UR - https://www.unboundmedicine.com/medline/citation/34744597/Acceptance_of_a_COVID_19_Vaccine_Before_it_is_Available_in_China_During_the_Pandemic_ DB - PRIME DP - Unbound Medicine ER -